• Je něco špatně v tomto záznamu ?

CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies

L. Siddiqui, N. Hasan, PK. Mishra, N. Gupta, AT. Singh, A. Madaan, M. Jaggi, S. Saad, A. Ekielski, Z. Iqbal, P. Kesharwani, S. Talegaonkar

. 2023 ; 643 (-) : 123270. [pub] 20230726

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016502

Hyaluronic acid (HA) coated irinotecan loaded lignin nanoparticles (HDLNPs) were synthesized using ionic interaction method. Optimized nanoparticles were characterized for their active chemotherapeutic targeting potential to CD44 receptors overly-expressed on cancer cells. Blood component interaction studies supported hemocompatible nature of HDLNPs and also demonstrated their sustained plasma residence property. Cell anti-proliferation and mitochondrial depolarization studies on HT-29 cells suggest significantly (p < 0.01) improved chemotherapeutic efficacy of HDLNPs. In vitro cell based studies showed that nanoparticles have retained antioxidant activity of lignin that can prevent cancer relapse. In vivo biodistribution studies in tumor-bearing Balb/c mice confirmed improved drug localization in tumor site for longer duration. Tumor regression and histopathological studies indicated the efficacy ofligand-assisted targeting chemotherapy over the conventional therapy. Hematological and biochemical estimation suggested that irinotecan-associated myelosuppression, liver steatosis and rare kidney failure can be avoided by its encapsulation in HA-coated lignin nanoparticles. HDLNPs were found to be stable over a period of 12 months.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016502
003      
CZ-PrNML
005      
20231026105751.0
007      
ta
008      
231013s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2023.123270 $2 doi
035    __
$a (PubMed)37499773
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Siddiqui, Lubna $u Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
245    10
$a CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies / $c L. Siddiqui, N. Hasan, PK. Mishra, N. Gupta, AT. Singh, A. Madaan, M. Jaggi, S. Saad, A. Ekielski, Z. Iqbal, P. Kesharwani, S. Talegaonkar
520    9_
$a Hyaluronic acid (HA) coated irinotecan loaded lignin nanoparticles (HDLNPs) were synthesized using ionic interaction method. Optimized nanoparticles were characterized for their active chemotherapeutic targeting potential to CD44 receptors overly-expressed on cancer cells. Blood component interaction studies supported hemocompatible nature of HDLNPs and also demonstrated their sustained plasma residence property. Cell anti-proliferation and mitochondrial depolarization studies on HT-29 cells suggest significantly (p < 0.01) improved chemotherapeutic efficacy of HDLNPs. In vitro cell based studies showed that nanoparticles have retained antioxidant activity of lignin that can prevent cancer relapse. In vivo biodistribution studies in tumor-bearing Balb/c mice confirmed improved drug localization in tumor site for longer duration. Tumor regression and histopathological studies indicated the efficacy ofligand-assisted targeting chemotherapy over the conventional therapy. Hematological and biochemical estimation suggested that irinotecan-associated myelosuppression, liver steatosis and rare kidney failure can be avoided by its encapsulation in HA-coated lignin nanoparticles. HDLNPs were found to be stable over a period of 12 months.
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    _2
$a irinotekan $x farmakologie $7 D000077146
650    _2
$a lignin $7 D008031
650    _2
$a tkáňová distribuce $7 D014018
650    12
$a nádory tračníku $x farmakoterapie $7 D003110
650    12
$a nanočástice $x chemie $7 D053758
650    _2
$a kyselina hyaluronová $x chemie $7 D006820
650    _2
$a antigeny CD44 $x metabolismus $7 D018960
650    _2
$a nádorové buněčné linie $7 D045744
650    12
$a antitumorózní látky $x chemie $7 D000970
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hasan, Nazeer $u Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
700    1_
$a Mishra, Pawan K $u Faculty of Business and Economics, Mendel University in Brno, Brno, Czech Republic. Electronic address: pawan.mishra@mendelu.cz
700    1_
$a Gupta, Neha $u Cell Biology Lab, Dabur Research Foundation, Ghaziabad, UP, India
700    1_
$a Singh, Anu T $u Cell Biology Lab, Dabur Research Foundation, Ghaziabad, UP, India
700    1_
$a Madaan, Alka $u Cell Biology Lab, Dabur Research Foundation, Ghaziabad, UP, India
700    1_
$a Jaggi, Manu $u Cell Biology Lab, Dabur Research Foundation, Ghaziabad, UP, India
700    1_
$a Saad, Suma $u Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
700    1_
$a Ekielski, Adam $u Department of Production Engineering, Warsaw University of Life Sciences, Poland
700    1_
$a Iqbal, Zeenat $u Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
700    1_
$a Kesharwani, Prashant $u Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
700    1_
$a Talegaonkar, Sushama $u Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Govt. of NCT of Delhi, New Delhi, India. Electronic address: stalegaonkar@dpsru.edu.in
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 643, č. - (2023), s. 123270
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37499773 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105746 $b ABA008
999    __
$a ok $b bmc $g 2000173 $s 1202864
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 643 $c - $d 123270 $e 20230726 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace